Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice ; volume:5 ; number:1 ; day:3 ; month:3 ; year:2016 ; pages:1-7 ; date:12.2016
SpringerPlus ; 5, Heft 1 (3.3.2016), 1-7, 12.2016
- Creator
-
Feiten, Stefan
- Contributor
-
Weide, Rudolf
Friesenhahn, Vera
Heymanns, Jochen
Kleboth, Kristina
Köppler, Hubert
Roye, Christoph van
Thomalla, Jörg
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-1851-z
- URN
-
urn:nbn:de:1111-2016031111490
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feiten, Stefan
- Weide, Rudolf
- Friesenhahn, Vera
- Heymanns, Jochen
- Kleboth, Kristina
- Köppler, Hubert
- Roye, Christoph van
- Thomalla, Jörg
- SpringerLink (Online service)
Other Objects (12)
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
Theranostic nuclear oncology in the management of metastatic cancer
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
Pan-cancer whole-genome analyses of metastatic solid tumours
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
Theranostic nuclear oncology in the management of metastatic cancer
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
Pan-cancer whole-genome analyses of metastatic solid tumours
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
Theranostic nuclear oncology in the management of metastatic cancer
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network
Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
Real-world treatment patterns and effectiveness among patients with metastatic colorectal cancer treated with ziv-aflibercept in community oncology practices in the USA
Pan-cancer whole-genome analyses of metastatic solid tumours
Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting